(Medical Xpress)—Whole-brain radiotherapy (WBRT) proves to be a positive therapeutic and survival tool in the treatment of brain tumors in adults, but the effect of WBRT on long-term brain function and performance is a ...
Oct 7, 2013
0
0
A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham). The method targets cancer stem cells—the ...
Sep 25, 2013
0
0
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of—and ultimately left no detectable trace of—brain tumor cells taken from adult ...
Sep 23, 2013
0
0
Cancer survivors who experience memory and thinking problems may benefit from cognitive rehabilitation, according to a new study led by Monique Cherrier, a UW associate professor of psychiatry and behavioral sciences.
Sep 20, 2013
0
0
(HealthDay)—A drug used against a common virus may lengthen the lives of people with a deadly form of brain cancer, a preliminary study suggests.
Sep 5, 2013
0
0
In the battle against brain cancer, doctors now have a new weapon—a new imaging technology that will make brain surgery dramatically more accurate by allowing surgeons to distinguish—at a microscopic level—between brain ...
Sep 4, 2013
0
0
A team of University of California, Riverside researchers have developed a novel transparent skull implant that literally provides a "window to the brain", which they hope will eventually open new treatment options for patients ...
Sep 3, 2013
0
0
(HealthDay)—Males may be the more vulnerable sex when it comes dying young—not just from accidents, but from a range of causes, a new study finds.
Sep 2, 2013
0
0
Researchers at the University of Cincinnati (UC) have identified a key protein as the first dual-function co-regulator of an estrogen receptor that plays a crucial role in cancer development, opening the way to improved therapeutic ...
Aug 30, 2013
0
0
Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas—the most common form of brain tumor—suggesting a new target for therapies for a cancer that does not respond ...
Aug 27, 2013
0
0
